Document is current
Any future updates will be listed below
-
Authors
Kishi, Satoru
Magalhães, Tiago A.
Cerci, Rodrigo J.
Zimmermann, Elke
Matheson, Matthew B.
Vavere, Andrea
Tanami, Yutaka
Kitslaar, Pieter H.
George, Richard T.
Brinker, Jeffrey
Miller, Julie M.
Clouse, Melvin E.
Lemos, Pedro A.
Niinuma, Hiroyuki
Reiber, Johan H. C.
Kofoed, Klaus F.
Rochitte, Carlos E.
Rybicki, Frank J.
Di Carli, Marcelo F.
Cox, Christopher
Lima, Joao A. C.
Arbab-Zadeh, Armin
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00934037 at ClinicalTrials.govDocuments that mention this clinical trial
Comparative effectiveness of coronary artery stenosis and atherosclerotic plaque burden assessment for predicting 30-day revascularization and 2-year major adverse cardiac events
https://doi.org/10.1007/s10554-020-01851-3
-
Funding
Funding for this research was provided by:
Toshiba Medical Systems
- License Information
-
More Information
Article History
Received: 31 March 2020
Accepted: 10 April 2020
First Online: 2 May 2020
Compliance with ethical standards
:
: Dr. J.H.C. Reiber has a part-time appointment as Professor of Medical Imaging at the Leiden University Medical Center (LUMC) and is the CEO of Medis medical imaging systems, Leiden, the Netherlands. Dr. P. Kitslaar has a research appointment at the LUMC, Division of Image Processing (LKEB), Department of Radiology and is an employee of Medis, Leiden, the Netherlands. Drs. F. Rybicki and A. Arbab-Zadeh disclose their membership of the CORE320 steering committee. The CORE320 study was sponsored by Canon (formerlyToshiba) Medical Systems. Dr. George and Mrs. Vavere have joined AstraZeneca as employees since completion of this research but disclose no conflicts to this topic.
: Approval for all research activities were obtained from local and central institutional review boards.
: All patients signed written consent to participate. Permission was obtained to publish the presented data.
